Altimmune (ALT) had the highest return between August 1, 2016 and August 31, 2017 by a small-cap US stock, returning 25,199,900%.
| ASSET | DATE | % RETURN |
|---|---|---|
Altimmune (ALT) | 8/1/2016 - 8/31/2017 | 25,199,900% |
HIVE Digital Technologies (HIVE) | 8/1/2016 - 8/31/2017 | 500% |
Evotec SE ADR (EVO) | 8/1/2016 - 8/31/2017 | 382.92% |
Cronos (CRON) | 8/1/2016 - 8/31/2017 | 380.72% |
Assembly Biosciences (ASMB) | 8/1/2016 - 8/31/2017 | 380.2% |
Abeona Therapeutics (ABEO) | 8/1/2016 - 8/31/2017 | 379.93% |
Esperion Therapeutics (ESPR) | 8/1/2016 - 8/31/2017 | 354.65% |
Gravity (GRVY) | 8/1/2016 - 8/31/2017 | 342.43% |
Pulse Biosciences (PLSE) | 8/1/2016 - 8/31/2017 | 340.22% |
Kronos Worldwide (KRO) | 8/1/2016 - 8/31/2017 | 291.85% |
New Pacific Metals (NEWP) | 8/1/2016 - 8/31/2017 | 270% |
Cryoport (CYRX) | 8/1/2016 - 8/31/2017 | 265.71% |
Fennec Pharmaceuticals (FENC) | 8/1/2016 - 8/31/2017 | 228.64% |
Northern Dynasty Minerals (NAK) | 8/1/2016 - 8/31/2017 | 225.45% |
Tronox (TROX) | 8/1/2016 - 8/31/2017 | 224.56% |
Palvella Therapeutics (PVLA) | 8/1/2016 - 8/31/2017 | 213.07% |
Weibo (WB) | 8/1/2016 - 8/31/2017 | 210.22% |
Safe Bulkers (SB) | 8/1/2016 - 8/31/2017 | 197.24% |
Canopy Growth (CGC) | 8/1/2016 - 8/31/2017 | 196.69% |
Willdan (WLDN) | 8/1/2016 - 8/31/2017 | 190.63% |
Hello (MOMO) | 8/1/2016 - 8/31/2017 | 189.27% |
Intrepid Potash (IPI) | 8/1/2016 - 8/31/2017 | 185.38% |
Paysign (PAYS) | 8/1/2016 - 8/31/2017 | 184.21% |
Tactile Systems Technology (TCMD) | 8/1/2016 - 8/31/2017 | 183.45% |
Nutex Health (NUTX) | 8/1/2016 - 8/31/2017 | 183.33% |
Small-cap stocks are treated as having a market cap between $300M and $2B.